Insider Sale: SVP of $PHR (PHR) Sells 11,853 Shares
Insider Sale: SVP of $PHR (PHR) Sells 11,853 Shares
David Linetsky, the SVP of $PHR ($PHR), sold 11,853 shares of the company on 12-11-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 5.9% of their shares. Following this trade, they now own 188,354 shares of $PHR stock.
$PHR($PHR)高級副總裁大衛·利內茨基於2024年11月12日出售了該公司的11,853股股票。我們從美國證券交易委員會最近的一份文件中收到了交易數據。這是他們約5.9%的股份的出售。在這筆交易之後,他們現在擁有188,354股的PHR股票。
$PHR Insider Trading Activity
$PHR 內幕交易活動
$PHR insiders have traded $PHR stock on the open market 41 times in the past 6 months. Of those trades, 0 have been purchases and 41 have been sales.
在過去的6個月中,$PHR內部人士在公開市場上交易了41次$PHR股票。在這些交易中,0筆是購買,41筆是銷售。
Here's a breakdown of recent trading of $PHR stock by insiders over the last 6 months:
以下是內部人士在過去6個月中最近交易的$PHR股票的明細:
- DAVID LINETSKY (SVP, Life Sciences) has traded it 12 times. They made 0 purchases and 12 sales, selling 18,850 shares.
- EVAN ROBERTS (Chief Operating Officer) has traded it 4 times. They made 0 purchases and 4 sales, selling 31,660 shares.
- AMY BETH VANDUYN (SVP, Human Resources) has traded it 4 times. They made 0 purchases and 4 sales, selling 27,182 shares.
- MICHAEL WEINTRAUB sold 15,152 shares.
- YVONNE HUI (Principal Accounting Officer) has traded it 5 times. They made 0 purchases and 5 sales, selling 4,241 shares.
- BALAJI GANDHI (Chief Financial Officer) has traded it 3 times. They made 0 purchases and 3 sales, selling 5,149 shares.
- ALLISON C HOFFMAN (General Counsel & Secretary) has traded it 5 times. They made 0 purchases and 5 sales, selling 20,816 shares.
- CHAIM INDIG (Chief Executive Officer) has traded it 4 times. They made 0 purchases and 4 sales, selling 11,035 shares.
- LISA EGBUONU-DAVIS sold 1,400 shares.
- MARK DOUGLAS SMITH sold 7,000 shares.
- JANET GUNZBURG (Principal Accounting Officer) sold 114 shares.
- 大衛·利內茨基(生命科學高級副總裁)已經進行了12次交易。他們進行了0次購買和12次銷售,出售了18,850股股票。
- 埃文·羅伯茨(首席運營官)已經進行了4次交易。他們進行了0次購買和4次銷售,出售了31,660股股票。
- 艾米·貝絲·範杜恩(人力資源高級副總裁)已經進行了4次交易。他們進行了0次購買和4次出售,出售了27,182股股票。
- 邁克爾·溫特勞布出售了15,152股股票。
- 許怡寧(首席會計官)已經交易了5次。他們進行了0次購買和5次銷售,出售了4,241股股票。
- 巴拉吉·甘地(財務長)已經進行了3次交易。他們進行了0次購買和3次銷售,出售了5,149股股票。
- 艾莉森·霍夫曼(總法律顧問兼秘書)已將其交易了5次。他們進行了0次購買和5次銷售,出售了20,816股股票。
- Chaim INDIG(首席執行官)已經進行了4次交易。他們進行了0次購買和4次銷售,出售了11,035股股票。
- LISA EGBUONU-DAVIS 出售了 1,400 股股票。
- 馬克·道格拉斯·史密斯出售了7,000股。
- 珍妮特·岡茨堡(首席會計官)出售了114股股票。
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
要追蹤內幕交易,請查看Quiver Quantization的內幕交易儀表板。
$PHR Hedge Fund Activity
$PHR 對沖基金活動
We have seen 104 institutional investors add shares of $PHR stock to their portfolio, and 92 decrease their positions in their most recent quarter.
我們已經看到104家機構投資者在其投資組合中增加了人民幣股票的股票,92家機構投資者在最近一個季度減少了頭寸。
Here are some of the largest recent moves:
以下是近期一些最大的走勢:
- UBS ASSET MANAGEMENT AMERICAS LLC added 1,761,169 shares (+3368.2%) to their portfolio in Q2 2024
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC removed 713,000 shares (-100.0%) from their portfolio in Q2 2024
- SILVERCREST ASSET MANAGEMENT GROUP LLC removed 606,465 shares (-66.8%) from their portfolio in Q3 2024
- GREENHOUSE FUNDS LLLP added 402,282 shares (+21.8%) to their portfolio in Q3 2024
- MILLENNIUM MANAGEMENT LLC added 356,771 shares (+inf%) to their portfolio in Q3 2024
- DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) added 352,101 shares (+183.1%) to their portfolio in Q3 2024
- GRANAHAN INVESTMENT MANAGEMENT, LLC added 270,895 shares (+22.9%) to their portfolio in Q3 2024
- 瑞銀資產管理美洲有限責任公司在2024年第二季度在其投資組合中增加了1,761,169股股票(+3368.2%)
- Summit PARTNERS 公共資產管理有限責任公司在2024年第二季度從其投資組合中刪除了71.3萬股股票(-100.0%)
- SilverCrest 資產管理集團有限責任公司在2024年第三季度從其投資組合中刪除了606,465股股票(-66.8%)
- GREENHOUSE FUNDS LLLP 在 2024 年第三季度在其投資組合中增加了 402,282 股(+21.8%)
- Millennium Management LLC 在 2024 年第三季度在其投資組合中增加了 356,771 股股票(+inf%)
- 迪爾菲爾德管理有限責任公司(C系列)在2024年第三季度在其投資組合中增加了352,101股股票(+183.1%)
- 格拉納漢投資管理有限責任公司在2024年第三季度在其投資組合中增加了270,895股股票(+22.9%)
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
要追蹤對沖基金的股票投資組合,請查看Quiver Quantization的機構持股儀表板。
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
本文不是財務建議。有關更多信息,請參閱 Quiver Quitizative 的免責聲明。